Halliburton Labs has announced the addition of three clean energy tech companies. Photo courtesy of Halliburton

Halliburton has again added a handful of energy tech startups to its Houston-based incubator.

Three companies — Matrix Sensors, Renew Power Systems, and SunGreenH2 — have joined Halliburton Labs as its newest clean energy participants.

“Companies across the energy landscape are interested in scalable innovations that improve the cost, reliability, and sustainability of energy,” says Managing Director Dale Winger in the news release. “Our tailored program combines expert support, access to a global network, and the physical resources for participants to scale. We’re excited to help these companies accelerate their market traction.”

Halliburton, a provider of energy equipment and services, launched Halliburton Labs in 2020. Last September was the incubator's last cohort addition. The next Halliburton Labs Finalists Pitch Day is Friday, January 27, at the Ion. The event will include pitches from 10 innovative, early-stage energy tech companies. Registration is open for the event.

Here are details, according to Halliburton, about the three new startups at the incubator.

Matrix Sensors

Using a new class of gas-adsorbing materials known as metal-organic frameworks to develop the world’s first quantitative gas sensor on a chip, Matrix Sensors has created a touch-free technology that enables advancements in sensor size, power, cost, and performance to address limitations of current gas sensor technologies, which require manual calibration every six months. The company is based in San Diego, California.

“With Halliburton’s global reach, we can apply our technology to some of the biggest problems facing the energy sector today, including CO2 sensors for energy efficient buildings and methane sensors for leak detection,” says Matrix Sensors CEO Steve Yamamoto in the release.

Renew Power Systems

RPSi, based in Minneapolis, Minnesota, is a clean-tech company that develops hardware and software solutions that enable flexible and sustainable grid infrastructure. RPSi uses power electronics to connect renewable energy resources, such as wind and solar, with each other and the grid.

“Our mission is to help change the way the world generates and distributes energy,” says CEO Zach Emond in the release. “With RPSi technology, a diverse range of domestic and global communities will benefit from the acceleration of renewable energy resources that work with new and existing grid infrastructure and improve access to affordable, sustainable, and resilient electricity.”

SunGreenH2

Singapore-based SunGreenH2 builds high-performance hardware for electrolyzer cells, stacks, and systems that increase hydrogen production, decrease energy use, and reduce platinum group metals use. The company supplies hardware components for alkaline and proton-exchange membrane electrolyzers. Its modular, high-efficiency anion exchange membrane (AEM) electrolyzer stack, which is being commercialized, uses renewable power to produce low-cost green hydrogen for industries, transport, and energy storage.

“We are excited to unlock the future of green hydrogen production. With the help of Halliburton’s engineering and manufacturing expertise, we plan to commercialize and roll out our product in major international markets,” says Tulika Raj, co-founder and CEO of the company, in the release.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Nominations are now open for the 2025 Houston Innovation Awards

Calling All Innovators

Calling all Houston innovators: The Houston Innovation Awards return this fall to celebrate the best and brightest in the Houston innovation ecosystem right now.

Presented by InnovationMap, the fifth annual Houston Innovation Awards will take place November 5 at TMC Helix Park.

The awards program will honor the top startups and innovators in Houston across 10 categories, and we're asking you to nominate the most deserving Houston innovators and innovative companies today.

This year's categories are:

  • Minority-founded Business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation.
  • Female-founded Business, honoring an innovative startup founded or co-founded by a woman.
  • Energy Transition Business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond.
  • Health Tech Business, honoring an innovative startup within the health and medical technology sectors.
  • Deep Tech Business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges, including those in the AI, robotics, and space sectors.
  • Startup of the Year (People's Choice), honoring a startup celebrating a recent milestone or success. The winner will be selected by the community via an interactive voting experience.
  • Scaleup of the Year, honoring an innovative later-stage startup that's recently reached a significant milestone in company growth.
  • Incubator/Accelerator of the Year, honoring a local incubator or accelerator that is championing and fueling the growth of Houston startups.
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support budding entrepreneurs.
  • Trailblazer, honoring an innovator who's made a lasting impact on the Houston innovation community.

Nominations may be made on behalf of yourself, your organization, and other leaders in the local innovation scene. The nomination period closes on August 31, so don't delay — nominate today at this link, or fill out the embedded form below.

Our panel of esteemed judges will review the nominations, and determine the finalists and winners. Finalists will be unveiled on September 30, and the 2025 Houston Innovation Awards winners will be announced live at our event on November 5.

Tickets will go on sale this fall. Stay tuned for that announcement, as well as more fanfare leading up to the 2025 Houston Innovation Awards.

Nominate now:

Interested in Innovation Awards sponsorship opportunities? Please contact sales@innovationmap.com.

MD Anderson launches $10M collaboration to advance personalized cancer treatment tech

fighting cancer

The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have announced a strategic collaboration to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.

The technology will be used as a tool for personalized cancer treatments and drug screening efforts, according to a release from MD Anderson. TOPPAN has committed $10 million over five years to advance the joint research activities.

“The strategic alliance with MD Anderson paves a promising path toward personalized cancer medicine," Hiroshi Asada, head of the Business Innovation Center at TOPPAN Holdings, said in a news release.

Invivoid is capable of establishing organoid models directly from patient biopsies or other tissues in a way that is faster and more efficient. Researchers may be able to test a variety of potential treatments in the laboratory to understand which approach may work best for the patient, if validated clinically.

“Organoids allow us to model the three-dimensional complexity of human cancers in the lab, thus allowing us to engineer a powerful translational engine—one that could not only predict how patients will respond to therapy before treatment begins but also could help to reimagine how we discover and validate next-generation therapies," Dr. Donna Hansel, division head of pathology and laboratory medicine at MD Anderson, added in the news release. “Through this collaboration, we hope to make meaningful progress in modeling cancer biology for therapeutic innovation.”

The collaboration will build upon preclinical research previously conducted by MD Anderson and TOPPAN. The organizations will work collaboratively to obtain College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certifications for the technology, which demonstrate a commitment to high-quality patient care. Once the certifications are obtained, they plan to conduct observational clinical studies and then prospective clinical studies.

“We believe our proprietary invivoid 3D cell culture technology, by enabling the rapid establishment of organoid models directly from patient biopsies, has strong potential to help identify more effective treatment options and reduce the likelihood of unnecessary therapies,” Asada added in the release. “Through collaboration on CAP/CLIA certification and clinical validation, we aim to bring this innovation closer to real-world patient care and contribute meaningfully to the advancement of cancer medicine."